Sign Up to like & get
recommendations!
0
Published in 2022 at "Journal of chromatographic science"
DOI: 10.1093/chromsci/bmac015
Abstract: Consumption of foods and dietary supplements (DS) adulterated with unprescribed or non-permitted phosphodiesterase-5 inhibitors (PDE-5i) and their analogs can cause serious risk to human health. This study aims to analyze 93 PDE-5i and their analogs…
read more here.
Keywords:
pde 5is;
pde analogs;
dietary supplements;
detection pde ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2023.1052546
Abstract: Introduction: Pulmonary arterial hypertension (PAH) is a rare and progressive disease. Some patients treated with phosphodiesterase type 5 inhibitors (PDE-5is) fail to reach treatment goals. As a novel soluble guanylate cyclase agonist, riociguat acts on…
read more here.
Keywords:
pde 5is;
riociguat;
arterial hypertension;
pulmonary arterial ... See more keywords